RILOTUMUMAB
UNII 51WEW898IJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Rilotumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 51WEW898IJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 872514-65-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

51WEW898IJ

CAS Registry Number

872514-65-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RILOTUMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C67079

National Cancer Institute reference terminology for clinical and research data.

INN ID

9123

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

SS-81

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rilotumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILOTUMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR) (HUMAN MONOCLONAL 2.12.1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 2.12.1 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G2, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR) (HUMAN MONOCLONAL 2.12.1 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL 2.12.1 LIGHT CHAIN, DIMER

RILOTUMUMAB [INN]

RILOTUMUMAB [USAN]

RILOTUMUMAB [WHO-DD]